BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 32100736)

  • 1. [ANMCO/AIGO Intersocietary consensus document: Gastroprotection in patients receiving antiplatelet and/or anticoagulant drugs].
    Abrignani MG; Zullo A; Gabrielli D; Milazzo G; De Francesco V; De Luca L; Francese M; Gatta L; Imazio M; Riccio E; Rossini R; Scotto Di Uccio F; Soncini M; Colivicchi F; Di Lenarda A; Gulizia MM; Monica F
    G Ital Cardiol (Rome); 2020 Mar; 21(3):228-241. PubMed ID: 32100736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO).
    Abrignani MG; Gatta L; Gabrielli D; Milazzo G; De Francesco V; De Luca L; Francese M; Imazio M; Riccio E; Rossini R; Scotto di Uccio F; Soncini M; Zullo A; Colivicchi F; Di Lenarda A; Gulizia MM; Monica F
    Eur J Intern Med; 2021 Mar; 85():1-13. PubMed ID: 33279389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Pump Inhibitors in Cardiovascular Disease: Drug Interactions with Antiplatelet Drugs.
    Würtz M; Grove EL
    Adv Exp Med Biol; 2017; 906():325-350. PubMed ID: 27628008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view.
    Abrignani MG; Lombardo A; Braschi A; Renda N; Abrignani V
    World J Cardiol; 2023 Aug; 15(8):375-394. PubMed ID: 37771340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining aspirin and proton pump inhibitors: for whom the warning bell tolls?
    Würtz M; Grove EL
    Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1051-5. PubMed ID: 22834712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel and proton pump inhibitors--where do we stand in 2012?
    Drepper MD; Spahr L; Frossard JL
    World J Gastroenterol; 2012 May; 18(18):2161-71. PubMed ID: 22611308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes.
    Mandurino-Mirizzi A; Leonardi S; Melloni C
    Minerva Endocrinol; 2017 Sep; 42(3):228-237. PubMed ID: 27808485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-induced gastrointestinal bleeding].
    Fischbach W
    Internist (Berl); 2019 Jun; 60(6):597-607. PubMed ID: 31076795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.
    Johnson DA; Chilton R; Liker HR
    Postgrad Med; 2014 May; 126(3):239-45. PubMed ID: 24918808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proton pump inhibitors and clopidogrel: an association to avoid?].
    D'Ugo E; Rossi S; De Caterina R
    G Ital Cardiol (Rome); 2012 Dec; 13(12):817-26. PubMed ID: 23196684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
    Laine L; Hennekens C
    Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Pump Inhibition in Patients Treated With Novel Antithrombotic Drugs: Should We Worry About Thrombosis?
    Bolek T; Samoš M; Škorňová I; Kovář F; Galajda P; Staško J; Kubisz P; Mokáň M
    J Cardiovasc Pharmacol; 2018 Jul; 72(1):71-76. PubMed ID: 29738377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.
    Melloni C; Washam JB; Jones WS; Halim SA; Hasselblad V; Mayer SB; Heidenfelder BL; Dolor RJ
    Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):47-55. PubMed ID: 25587094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
    Lettino M
    Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study.
    Nagata N; Niikura R; Yamada A; Sakurai T; Shimbo T; Kobayashi Y; Okamoto M; Mitsuno Y; Ogura K; Hirata Y; Fujimoto K; Akiyama J; Uemura N; Koike K
    PLoS One; 2016; 11(3):e0151332. PubMed ID: 26978517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet therapy and proton pump inhibition: cause for concern?
    Depta JP; Bhatt DL
    Curr Opin Cardiol; 2012 Nov; 27(6):642-50. PubMed ID: 23075823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding.
    Ray WA; Chung CP; Murray KT; Smalley WE; Daugherty JR; Dupont WD; Stein CM
    Gastroenterology; 2016 Dec; 151(6):1105-1112.e10. PubMed ID: 27639805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clopidogrel--proton pump inhibitors drug interaction: implications to clinical practice].
    Fontes-Carvalho R; Albuquerque A
    Rev Port Cardiol; 2010 Oct; 29(10):1555-67. PubMed ID: 21268429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of proton-pump inhibitors on the risk of lower gastrointestinal bleeding associated with NSAIDs, aspirin, clopidogrel, and warfarin.
    Nagata N; Niikura R; Aoki T; Sakurai T; Moriyasu S; Shimbo T; Sekine K; Okubo H; Watanabe K; Yokoi C; Yanase M; Akiyama J; Uemura N
    J Gastroenterol; 2015 Nov; 50(11):1079-86. PubMed ID: 25700638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
    Tran M; Tafreshi J; Pai RG
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.